Today, the FDA took important steps to advance the FDA’s regulatory process for intentional genomic alterations (IGAs) in animals.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA will host a listening session in June as part of broader work to optimize the use of, and processes, for advisory committees.

Today, the U.S. Food and Drug Administration took action aimed at helping to ensure the safety and effectiveness of laboratory developed tests.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Today, the FDA approved a new treatment for female adults with uncomplicated urinary tract infections caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus.